MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    Evaluation clinical-biochemical features of Parkinson’s disease

    D. Daminov, G. Rakhmatullaeva (Tashkent, Uzbekistan)

    Objective: To study the features of the cytokine status under different forms and variants of PD course. Background: Parkinson’s disease is clinically heterogeneous; the etiology…
  • 2018 International Congress

    Safety of sublingual apomorphine film (APL-130277) for the treatment of OFF episodes in patients with Parkinson’s disease: Results from a Phase 3 double-blind, placebo-controlled trial

    R. Pahwa, R. Hauser, M. Worden, P. Bhargava, G. Vakili, A. Agro, D. Blum, W. Olanow, B. Navia (Kansas City, KS, USA)

    Objective: To evaluate the safety of APL-130277 (APL) in the double-blind, placebo-controlled trial Titration Phase (TP) and Maintenance Phase (MP). Background: OFF episodes are a…
  • 2018 International Congress

    Impact on the Quality of Life (CV) of people with Parkinson’s disease participating in community workshops of the public health system of Coquimbo, Chile

    S. Stange, D. Mansilla, Y. Diaz, Y. Córdoba (Coquimbo, Chile)

    Objective: To show the Impact in the CV of the People with Parkinson's Disease through the permanent assistance to the multidisciplinary community workshops of their…
  • 2018 International Congress

    The first case of Perry syndrome in Estonia

    K. Vender, T. Toomsoo, I. Kalju, I. Rubanovits, K. Joost, P. Taba (Tallinn, Estonia)

    Objective: Perry syndrome is an autosomal dominant disorder characterized by progressive parkinsonism and central hypoventilation. Background: Since the original publication in 1975 there have been…
  • 2018 International Congress

    Surgery-, hardware – and chronic stimulation-related adverse events following subthalamic nucleus deep brain stimulation for Parkinson’s disease

    B. Gonenli Kocer, E. Ozturk, S. Comoglu, M. Sorar, H. Kertmen (Ankara, Turkey)

    Objective: To evaluate the adverse events (AEs) following subthalamic nucleus (STN) deep brain stimulation (DBS) for Parkinson’s disease (PD) during 6 years period. Background: The…
  • 2018 International Congress

    Phenotypic Heterogeneity and Variability of Nigrostriatal Dopaminergic Function in a Dopa-Responsive Dystonia

    J.J. Lin (Nantou, Taiwan)

    Objective: To evaluate presynaptic nigrostriatal dopaminergic function in a Dopa-responsive dystonia (DRD) family with guanosine triphosphate cyclohydrolase 1 (GCH-1) mutation. Background: Mutation of GCH-1 located…
  • 2018 International Congress

    A nationwide epidemiological study of Parkinson’s disease in Korea using national health insurance database

    WW. Lee, B. Jeon, BK. Kim, HJ. Kim (Seoul, Republic of Korea)

    Objective: To investigate the incidences and prevalences, and those male-to-female ratios of PD patients in Korea. Background: The epidemiological studies of Parkinson’s disease (PD) are…
  • 2018 International Congress

    Speech and Language Therapy (SLT) for Inpatients with Parkinson’s (IwP) in a Large District General Hospital

    J. Martin, A. Chatterjee (Reading, United Kingdom)

    Objective: To improve access to SLT for the MDT and IwP at the Royal Berkshire Hospital. Background: A successful bid in Jan 2017 for a…
  • 2018 International Congress

    Clinical experiences in Whole systems Ayurveda Management of Parkinson’s Disease

    P. Shankar, P. R, P. Devkumar, A. Godbole, U. Muthane (Bangalore, India)

    Objective: PD Assessment of Ayurveda management using UPDRS -Motor, Hoehn & Yahr staging, Activity of Daily Living % (ADL). Background: Ayurveda holistic management comprises an…
  • 2018 International Congress

    Olfactory testing in Parkinson plus syndromes

    O. Abdukarimov, F. Akhmedova (Tashkent, Uzbekistan)

    Objective: To determine the diagnostic utility of olfactory testing in patients with neurodegenerative Parkinsonism. Background: Olfactory dysfunction can be identified in the vast majority of…
  • « Previous Page
  • 1
  • …
  • 287
  • 288
  • 289
  • 290
  • 291
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley